Zhejiang Jiuzhou Pharmaceutical announced that its wholly-owned subsidiary Zhejiang Siwei Medical Technology Co., Ltd. recently received the GMP certificate issued by the United Kingdom Pharmaceutical and Health Products Regulatory Agency. The scope of this inspection is the tablet production line, from July 29, 2024 to July 31, 2024. This certification is the first time that Siwei Medical Technology has passed the UK GMP certification, indicating that its pharmaceutical GMP quality management system and production environment facilities meet the requirements of the UK MHRA, providing a guarantee for the company to expand into the international market.
九洲药业：全资子公司通过英国GMP认证
Zhejiang Jiuzhou Pharmaceutical: Wholly-owned subsidiary passed the United Kingdom GMP certification.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated